Skip to content

Author

Vrushabh Patil

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Recent Advances and Challenges in Addressing Drug-induced Liver Injury (DILI): Mechanisms and Nanocarrier Solutions.

INTRODUCTION Drug-Induced Liver Injury (DILI) is a leading cause of drug attrition, postmarketing withdrawals, and acute liver failure. It presents a major barrier to the safe development of new therapeutics, particularly due to its unpredictable pathogenesis and the lack of reliable preclinical models. Current diagnos...

Ashok Thulluru, Vrushabh Patil, C. Jangme et al. · 0 citations
Sep 2026

Nanostructured Cubosomal Gels for Targeted Drug Delivery in Rheumatoid Arthritis: Advances in Nanomedicine and Therapeutic Nanotechnology.

Introduction/ Objective: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovial joints, leading to joint destruction and systemic complications. Existing therapies, such as Disease-Modifying Antirheumatic Drugs (DMARDs) and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs),...

Ashok Thulluru, C. Jangme, Vrushabh Patil · 0 citations
Review Sep 2026

Heat Shock Protein 90 as a Master Regulator of Multidrug Resistance: Small-molecule Inhibitors, Prodrugs, Hybrid Molecules, Antibody-drug Conjugates, and Nanotechnology-based Delivery Systems.

INTRODUCTION/OBJECTIVE Multidrug Resistance (MDR) remains a major obstacle to effective cancer chemotherapy, driven by multiple interconnected mechanisms, including overexpression of ATP-binding Cassette (ABC) transporters, enhanced DNA repair, apoptosis evasion, and protumorigenic microenvironmental factors. Heat Shoc...

Sundeep Kadasi, A. Kholkumbe, C. Jangme et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.